ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

7.82

-0.25 (-3.16%)

At close: Mar 30, 2026, 4:00 PM EDT

7.99

+0.17 (2.24%)

Pre-market: Mar 31, 2026, 4:39 AM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Pharmaceuticals	84.28M	89.15M	30.00K	1.32M	5.51M
Pharmaceuticals Growth	-5.46%	297063.33%	-97.72%	-76.10%	-69.13%
Total	84.28M	89.15M	30.00K	1.32M	5.51M
Total Growth	-5.46%	297063.33%	-97.72%	-76.10%	-69.13%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
United States	72.19M	7.26M	30.00K	1.32M	5.51M
United States Growth	895.07%	24083.33%	-97.72%	-76.10%	-69.13%
Rest of World	12.09M	81.89M	-	-	-
Rest of World Growth	-85.24%	-	-	-	-
Total	84.28M	89.15M	30.00K	1.32M	5.51M
Total Growth	-5.46%	297063.33%	-97.72%	-76.10%	-69.13%

Source: S&P Global Market Intelligence.